What is the RADARS System?
RADARS System Data
RADARS System data have been utilized by manufacturers, regulatory agencies, and medical and public health officials to characterize and monitor prescription drug abuse, misuse, and diversion. The data have been presented at several United States (US) Food and Drug Administration (FDA) advisory committee meetings and scientific meetings as well as in reports to the FDA, new drug applications, labeling claims, postmarketing requirements, and Risk Evaluation and Mitigation Strategies (REMS) evaluation. Data may also be used for the development of interventions, to assess the impact of interventions (i.e. abuse deterrent formulations), and to monitor everchanging market trends.
New Program in Development:
Pain Patient Program
Survey of Non-Medical Use of Prescription Drugs program launched
Web Monitoring program launched
RAPID program launched
StreetRx program launched
Survey of Key Informants' Patients Program launched
DHHA acquires ownership of RADARS System
Opioid Treatment program launched
Poison Center Program launched
Drug Diversion program launched
Purdue Pharma LP launched RADARS System